Integrated BioPharma, Inc. (OTCMKTS:INBP) Sees Significant Growth in Short Interest

Integrated BioPharma, Inc. (OTCMKTS:INBP) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 4,800 shares, an increase of 1,500.0% from the February 28th total of 300 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 16,900 shares, the days-to-cover ratio is currently 0.3 days.

Integrated BioPharma Stock Performance

Shares of INBP stock opened at $0.34 on Friday. Integrated BioPharma has a twelve month low of $0.16 and a twelve month high of $0.42. The stock has a market cap of $10.30 million, a P/E ratio of 11.34 and a beta of 0.89. The stock has a 50 day moving average of $0.33 and a 200 day moving average of $0.31.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.